Oligometastatic Renal Cell Carcinoma clinical trials

Explore recruiting oligometastatic renal cell carcinoma clinical trials.

Recruiting oligometastatic renal cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligometastatic Renal Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of PErioperative PEmbrolizumab treatment in patients with resectable metastases from kidney cancer. The PE-PE study

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Oligometastatic Renal Cell Carcinoma trials by city

Oligometastatic Renal Cell Carcinoma clinical trials

Recruiting oligometastatic renal cell carcinoma studies right now

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma

Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)

A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

Also recruiting in Europe

Efficacy of PErioperative PEmbrolizumab treatment in patients with resectable metastases from kidney cancer. The PE-PE study

Oligometastatic Renal Cell Carcinoma trials by city

Other conditions